Imatinib Mesylate in Treating Patients With Gliomas

Clinical trial NCT00039364 · COMPLETED

Trial details

NCT number: NCT00039364
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2002-03-01
Primary completion: 2004-08-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.